Atomfair Resiquimod R-848 C17H22N4O2

Description Resiquimod (CAS No. 144875-48-9) is a high-purity synthetic imidazoquinoline compound with the molecular formula C17H22N4O2. This small molecule immunostimulant is chemically designated as 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol and is provided as a white to off-white crystalline powder. Resiquimod is a potent Toll-like receptor (TLR) 7 and TLR8 agonist known for its ability to induce cytokine production, particularly interferon-alpha, making it valuable for immunological research. Our product is rigorously tested by HPLC and NMR to ensure >98% purity, with batch-specific certificates of analysis available. Suitable for in vitro and in vivo studies, this compound is provided in amber vials under inert atmosphere to…

Description

Description

Resiquimod (CAS No. 144875-48-9) is a high-purity synthetic imidazoquinoline compound with the molecular formula C17H22N4O2. This small molecule immunostimulant is chemically designated as 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol and is provided as a white to off-white crystalline powder. Resiquimod is a potent Toll-like receptor (TLR) 7 and TLR8 agonist known for its ability to induce cytokine production, particularly interferon-alpha, making it valuable for immunological research. Our product is rigorously tested by HPLC and NMR to ensure >98% purity, with batch-specific certificates of analysis available. Suitable for in vitro and in vivo studies, this compound is provided in amber vials under inert atmosphere to ensure stability. Store at -20??C protected from light and moisture.

  • CAS No: 144875-48-9
  • Molecular Formula: C17H22N4O2
  • Molecular Weight: 314.4
  • Exact Mass: 314.17427596
  • Monoisotopic Mass: 314.17427596
  • IUPAC Name: 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol
  • SMILES: CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N
  • Synonyms: Resiquimod, 144875-48-9, 1-(4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol, Resiquimod [INN], R 848

Application

Resiquimod is widely used as a research tool for studying innate immune responses through its action as a dual TLR7/TLR8 agonist. The compound has shown utility in preclinical studies of antiviral therapies, cancer immunotherapy, and vaccine adjuvants. Researchers employ Resiquimod to investigate cytokine induction pathways, particularly interferon-mediated antiviral defenses. Its ability to stimulate dendritic cell maturation makes it valuable for immunological studies. Recent applications include exploration of topical formulations for dermatological conditions.

If you are interested or have any questions, please contact us at support@atomfair.com